Molica S, Shanafelt TD, Giannarelli D, Allsup D. Ibrutinib versus acalabrutinib in fixed-duration chronic lymphocytic leukemia therapy: a comparative analysis of efficacy. haematol [Internet]. 2026Jan.1 [cited 2026Mar.25];111(1):412-7. Available from: https://haematologica.org/article/view/12163